Research directory

Drugs

Search by drug name or a recorded alias for a verified drug. Open its page to see linked trials and published FDA events.

1840 drugs

Part 2 (OLE Treatment) - AL001

Drug identity checked against registry

Part 2: VP-315 2 Day Dosing/Week - Split Dose

Drug identity checked against registry

Part 2: VP-315 3 Day Dosing/Week - Loading Dose

Drug identity checked against registry

Part 2: VP-315 3 Day Dosing/Week - No Loading Dose

Drug identity checked against registry

Part 2: VP-315 3 Day Dosing/Week - Split Dose

Drug identity checked against registry

Part A: 20 and 40 mg PRAX-944

Drug identity checked against registry

Part A: Upamostat 200 mg

Drug identity checked against registry

Part A: Upamostat 400 mg

Drug identity checked against registry

Part B: 120 mg PRAX-944

Drug identity checked against registry

Part B: Upamostat 200 or 400 mg

Drug identity checked against registry

Patidegib Topical Gel

Drug identity checked against registry

Patidegib Topical Gel with no active patidegib

Drug identity checked against registry

Patidegib Topical Gel, 2%

Drug identity checked against registry

Patidegib Topical Gel, Vehicle

Drug identity checked against registry

Paxalisib (GDC-0084)

Drug identity checked against registry

Paxlovid

Drug identity checked against registry

Pazopanib

Drug identity checked against registry

Peg-IFNα

Drug identity checked against registry

Peg-IFNα-2a

Drug identity checked against registry

Pegfilgrastim

Drug identity checked against registry

Pegtibatinase

Drug identity checked against registry

Pegylated Liposomal Doxorubicin Hydrochloride (PLD)

Drug identity checked against registry

Pegylated liposomal doxorubicin

Drug identity checked against registry

Pelareorep

Drug identity checked against registry

Pembrolizumab

Drug identity checked against registry

Pembrolizumab (KEYTRUDA® )

Drug identity checked against registry

Pembrolizumab (KEYTRUDA®)

Drug identity checked against registry

Pembrolizumab (KEYTRUDA®) and PDS0101

Drug identity not yet verified

Pembrolizumab (MK-3475) 200 mg

Drug identity checked against registry

Pembrolizumab + Carboplatin + Nab-paclitaxel or Paclitaxel

Drug identity checked against registry